ALZHEIMER BLOOD BIOMARKERS
Clinical trials for ALZHEIMER BLOOD BIOMARKERS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER BLOOD BIOMARKERS trials appear
Sign up with your email to follow new studies for ALZHEIMER BLOOD BIOMARKERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: drug may stop seizures in down syndrome Alzheimer's patients
Prevention Recruiting nowThis study tests if levetiracetam, a seizure medication, can prevent epileptic seizures in 120 adults over 40 with Down syndrome and Alzheimer's disease. Participants will receive either the drug or a placebo for 96 weeks. The goal is to see if the drug can stop seizures and poss…
Matched conditions: ALZHEIMER BLOOD BIOMARKERS
Phase: PHASE3 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Prevention
Last updated May 16, 2026 23:37 UTC
-
Could a weekly insulin boost help Alzheimer's patients think clearer?
Symptom relief Recruiting nowThis study tests whether giving insulin in short weekly sessions can improve how the body uses sugar and how well people with Alzheimer's think and remember. Eight adults will receive the treatment for six months and take memory tests. The goal is to see if this approach is safe …
Matched conditions: ALZHEIMER BLOOD BIOMARKERS
Phase: NA • Sponsor: Pennington Biomedical Research Center • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC